IM Cannabis Corp. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on November 13, 2025, by IM Cannabis Corp., a foreign private issuer based in Israel, reports on the Company's financial performance for the three and nine months ended September 30, 2025. The filing incorporates by reference the Unaudited Interim Condensed Consolidated Financial Statements, Management's Discussion and Analysis (MD&A), and a press release issued on September 13, 2025.
Key Financial Metrics
The provided text serves as a cover sheet and exhibit index. It does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached exhibits (Exhibit 99.2 and Exhibit 99.3) which are not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. Such analysis is contained within the attached MD&A (Exhibit 99.3) and the press release (Exhibit 99.1).
Guidance, Outlook, and Risks
Management commentary, outlook, and risk factors are referenced as being included in the attached press release and MD&A but are not detailed in the cover document. The filing confirms the incorporation of these documents into the Company's Registration Statements on Form F-3.
Investor Verification Checklist
- Review Exhibit 99.2 for specific revenue, net income, and cash flow figures for the three and nine months ended September 30, 2025.
- Examine Exhibit 99.3 (MD&A) for management's explanation of operational results and material changes compared to prior periods.
- Read Exhibit 99.1 (Press Release) for forward-looking statements, guidance, and strategic updates.
- Verify the certifications provided by the CEO and CFO in Exhibits 99.4 and 99.5 regarding the accuracy of the interim filings.